Yves Sabbagh

Yves Sabbagh

Company: Inozyme Pharma

Job title: SVP & Chief Scientific Officer

Seminars:

Panel Discussion: Innovating ERT Modalities to Expand the Array of Options Available to Patients 10:00 am

Look back at what advancement have been made in the field and where the new opportunities could lie Analyze case studies of innovations that have been successful and unsuccessfulRead more

day: Day Two

Single ERT to Address Calcification Disorders with Overlapping Phenotype 9:30 am

ENPP1 and ABCC6 Deficiency are rare genetic calcification disorders with high unmet medical need and no approved therapy Both disorders have low circulating levels of pyrophosphate, a potent inhibitor of calcification, leading to vascular calcification and other complications affecting soft tissues and the skeleton Using an ERT approach with ENPP1-Fc protein, proof of concept was…Read more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.